Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
During the Civil Rights Movement, disabled activists helped shape new legal protections. Decades later, local self-advocates ...
Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback